Computational screening of phthalate monoesters for binding to PPARγ

Chemical Research in Toxicology

Volumn 19, Issue 8, 2006, Pages 999-1009

  Kaya, Taner ^a,b   Mohr, Scott C ^a   Waxman, David J ^a   Vajda, Sandor ^b  

^a Boston University   (United States)

^b Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; FARGLITAZAR; GW 0072; GW 409544; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PHTHALIC ACID DERIVATIVE; RAGAGLITAZAR; ROSIGLITAZONE; TESAGLITAZAR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCULATION; CHEMICAL BINDING; CORRELATION ANALYSIS; MATHEMATICAL COMPUTING; MOLECULAR INTERACTION; MOLECULAR MODEL; ORIENTATION; PRODUCT RECOVERY; RELIABILITY; SOLVATION; SURFACE PROPERTY; TRANSACTIVATION; VALIDATION PROCESS;

BINDING, COMPETITIVE; COMPUTATIONAL BIOLOGY; ESTERS; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHTHALIC ACIDS; PPAR GAMMA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33748636897     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050301s     Document Type: Article

References (46)

1. Cadogan, D. F. (1999) Plasticizers. In Kirk-Othmer Concise Encyclopedia of Chemical Technology (Kroschwitz, J. I., Ed.) pp 1577-1582, Wiley, New York.
2. Blount, B. C., Silva, M. J., Caudill, S. P., Needham, L. L., Pirkle, J. L., Sampson, E. J., Lucier, G. W., Jackson, R. J., and Brock, J. W. (2000) Levels of seven urinary phthalate metabolites in a human reference population. Environ. Health Perspect. 108, 979-982.
3. Silva, M. J., Barr, D. B., Reidy, J. A., Malek, N. A., Hodge, C. C., Caudill, S. P., Brock, J. W., Needham, L. L., and Calafat, A. M. (2004) Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ. Health Perspect. 112, 331-338.
4. Tickner, J. A., Schettler, T., Guidotti, T., McCally, M., and Rossi, M. (2001 ) Health risks posed by use of di-2-ethylhexyl phthalate (DEHP) in PVC medical devices: a critical review. Am. J. Ind. Med. 39, 100-111.
5. David, R. M., Moore, M. R., Cifone, M. A., Finney, D. C., and Guest, D. (1999) Chronic peroxisome proliferation and hepatomegaly associated with the hepatocellular tumorigenesis of di(2-ethylhexyl)-phthalate and the effects of recovery. Toxicol. Sci. 50, 195-205.
6. Lovekamp-Swan, T., and Davis, B. J. (2003) Mechanisms of phthalate ester toxicity in the female reproductive system. Environ. Health Perspect. 111, 139-145.
7. Hurst, C. H., and Waxman, D. J. (2003) Activation of PPARα and PPARγ by environmental phthalate monoesters. Toxicol. Sci. 74, 297-308.
8. Swan, S. H., Main, K. M., Liu, F., Stewart, S. L., Kruse, R. L., Calafat, A. M., Mao, C. S., Redmon, J. B., Ternand, C. L., Sullivan, S., and Teague, J. L. (2005) Study for Future Families Research (2005). Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ. Health Perspect. 113 (8), 1056-1061.
9. Lampen, A., Zimnik, S., and Nau, H. (2003). Teratogenic phthalate esters and metabolites activate the nuclear receptors PPARs and induce differentiation of F9 cells. Toxicol. Appl. Pharmacol. 188, 14-23.
10. Jones, G., Willett, P., and Glen, R. C. (1995). Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245, 43-53.
11. Jones, G., Willett, P., Glen, R. C., Leach, A. R., and Taylor, R. (1997). Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267, 727-748.
12. Nissink, J. W. M., Murray, C., Hartshorn, M., Verdonk, M. L., Cole, J. C., and Taylor, R. (2002) A new test set for validating predictions of protein-ligand interaction. Proteins 49, 457-471.
13. Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., and Taylor, R. D. (2003) Improved protein-ligand docking using GOLD. Proteins 52, 609-623.
14. Ferrara, P., Gohlke, H., Price, D. J., Klebe, G., and Brooks, C. L., 3rd (2004) Assessing scoring functions for protein-ligand interactions. J. Med. Chem. 47, 3032-3047.
15. Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., and Milburn, M. V. (1998) Ligand binding and co-activator assembly of the peroxisome proliferators-activated receptor-γ. Nature 395, 137-144.
16. Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Jr., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., and Tasumi, M. (1977) The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542.
17. Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., and Karplus, M. (1983) CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4, 187-217.
18. MacKerell, A. D., Jr., Brooks, B., Brooks, C. L., Nilsson, L., III, Roux, B., Won, Y., and Karplus, M. (1998) CHARMM: The energy function and its parametrization with an overview of the program. Encycl. Comput. Chem. 1, 271-277.
19. Schaefer, M., and Karplus, M. A. (1996) A comprehensive analytical treatment of continuum electrostatics. J. Phys. Chem. 100, 1578-1599.
20. Adams, A. D., Yuen, W., Hu, Z., Santini, C, Jones, A. B., MacNaul, K. L., Berger, J. P., Doebber, T. W., Moller, D. E. (2003) Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human PPAR γδ and α agonists. Bioorg. Med. Chem. Lett. 13, 931-935.
21. Sauerberg, P., Pettersson, I., Jeppesen, L., Bury, P. S., Mogensen, J. P., Wassermann, K., Brand, C. L., Sturis, J., Woldike, H. F., Fleckner, J., Andersen, A. S., Mortensen, S. B., Svensson, L. A., Rasmussen, H. B., Lehmann, S. V., Polivka, Z., Sindelar, K., Panajotova, V., Ynddal, L., and Wulff, E. M. (2002). Novel tricyclic-α-alkyloxyphenylpropionic acids: Dual PPAR α/γ agonists with hypolipidemic and antidiabetic activity. J. Med. Chem. 45, 789-804.
22. Cronet, P., Petersen, J. F., Folmer, R., Blomberg, N., Sjoblom, K., Karlsson, U., Lindstedt, E. L., and Bamberg, K. (2001) Structure of the PPARα and -γ ligand binding domain in complex with AZ242; Ligand selectivity and agonist activation in the PPAR family. Structure 9, 699-706.
23. Xu, H. E., Lambert, M. H., Montana, V. G., Plunket, K. D., Moore, L. B., Collins, J. L., Oplinger, J. A., Kliewer, S. A., Gampe, R. T., Jr., McKee, D. D., Moore, J. T., and Willson, T. M. (2001) Determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. U.S.A. 98, 13919-13924.
24. Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliewer, S. A., Willson, T. M., and Xu, H. E. (2000) Asymmetry in the PPARγ/RXRα crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol. Cell 5, 545-555.
25. Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., Parks, D. J., Moore, L. B., Lehmann, J. M., Plunket, K., Miller, A. B., Milburn, M. V., Kliewer, S. A., and Willson, T. M. (1999) A peroxisome proliferators-activated receptor γ inhibits adipocyte differentiation. Proc. Natl. Acad. Sci. U.S.A. 96, 6102-6106.
26. Berger, J., and Moller, D. E. (2002) The mechanism of action of PPARs. Annu. Rev. Med. 53, 409-435.
27. Nettles, K. W., Sun, J., Radek, J. T., Sheng, S., Rodriguez, A. L., Katzenellenbogen, J. A., Katzenellenbogen, B. S., and Greene, G. L. (2004) Allosteric control of ligand selectivity between estrogen receptors α and β: Implications for other nuclear receptors. Mol. Cell 13, 317-327.
28. Nagy, L., and Schwabe, J. W. R. (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci. 29, 317-324.
29. Li, Y., Lambert, M. H., and Xu, H. E. (2003) Activation of nuclear receptors: A perspective from structural genomics. Structure 11, 141-746.
30. Gasteiger, J., and Marsili, M. (1978) A new model for calculating atomic charges in molecules. Tetrahedron Lett. 3181-3184.
31. Walters, P., and Stahl, M. BABEL, Department of Chemistry, University of Arizona, 1992.
32. Pissios, P., Tzameli, I., Kushner, P., and Moore, D. D. (2000) Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding. Mol. Cell 6, 245-253.
33. Sheu, S.-H., Kaya, T., Waxman D. J., and Vajda, S. (2005) Exploring the binding site structure of the PPAR-γ ligand binding domain by computational solvent mapping. Biochemistry 44, 1193-1209.
34. Erickson, J. A., Jalaie, M., Robertson, D. H., Lewis, R. A., and Vieth, M. (2004) Lessons in molecular recognition: The effects of ligands and protein flexibility on molecular docking accuracy. J. Med. Chem. 47, 45-55.
35. Connolly, M. L. (1983) Solvent-accessible surfaces of proteins and nucleic acids. Science 221, 709-713.
36. Zoete, V., Michielin, O., and Karplus, M. (2003) Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors. J. Comput.-Aided Mol. Des. 17, 861-880.
37. Zoete, V., Meuwly, M., and Karplus, M. (2005) Study of the insulin dimerization: Binding free energy calculations and per-residue free energy decomposition. Proteins 61, 79-93.
38. Kellenberger, E., Rodrigo, J., Muller, P., and Rognan, D. (2004) Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 57, 225-242.
39. Kontoyianni, M., McClellan, L. M., and Sokol, G. S. (2004) Evaluation of docking performance: Comparative data on docking algorithms. J. Med. Chem. 47, 558-565.
40. Perola, E., Walters, W. P., and Charifson, P. S. (2004) A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance. Proteins 56, 235-249.
41. Cummings, M. D., DesJarlais, R. L., Gibbs, A. C., Mohan, V., and Jaeger, E. P. (2005) Comparison of automated docking programs as virtual screening tools. J. Med. Chem. 48, 962-976.
42. Wang, R., Lu, Y., and Wang, S. (2003) Comparative evaluation of 11 scoring functions for molecular docking. J. Med. Chem. 46, 2287-2303.
43. Wang, R., Lu, Y., Fang, X., and Wang, S. (2004) An extensive test of 14 scoring functions using the PDBbind refined set of 800 protein-ligand complexes. J. Chem. Inf. Comput. Sci. 44, 2114-2125.
44. Mohan, V., Gibbs, A. C., Cummings, M. D., Jaeger, E. P., and DesJarlais, R. L. (2005) Docking: Successes and challenges. Curr. Pharm. Des. 11, 323-333.
45. Charifson, P. S., Corkery, J. J., Murcko, M. A., and Walters, W. P. (1999) Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J. Med. Chem. 42, 5100-5109.
46. Paul, N., and Rognan, D. (2002) ConsDock: A new program for the consensus analysis of protein-ligand interactions. Proteins 47. 521-533.